Valuation: NORW ACQUPAR

Market Cap 13.37M 11.62M 10.85M 9.96M 18.78M 1.27B 19.11M 128M 50.1M 636M 50.22M 49.11M 2.1B P/E 2023
96.6x
P/E 2024 -6.98x
Enterprise Value 23.05M 20.04M 18.71M 17.17M 32.38M 2.2B 32.94M 221M 86.39M 1.1B 86.6M 84.68M 3.61B EV / Sales 2023
-
EV / Sales 2024 -
Free-Float
-
Yield 2023 *
-
Yield 2024 -
1 day-9.19%
Current month-61.50%
Current year-61.50%
3 years 0.88
Extreme 0.8801
13
5 years 0.88
Extreme 0.8801
13
10 years 0.88
Extreme 0.8801
13

Financials

2023 2024
Net sales - -
Net income 1.16M 1.01M 943K 865K 1.63M 111M 1.66M 11.12M 4.35M 55.23M 4.36M 4.27M 182M -8.71M -7.57M -7.07M -6.49M -12.24M -830M -12.45M -83.35M -32.64M -414M -32.72M -32M -1.37B
Net Debt 940K 817K 762K 700K 1.32M 89.56M 1.34M 8.99M 3.52M 44.66M 3.53M 3.45M 147M 9.68M 8.42M 7.86M 7.21M 13.6M 923M 13.84M 92.64M 36.28M 460M 36.37M 35.57M 1.52B
Logo NORW ACQUPAR
NorthView Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The Company intends to focus its search on businesses that are focused on the biopharmaceutical, medical technology/medical device, and diagnostics space, which aligns with the management team’s experience in operating health care companies and in drug and device technology development as well as diagnostic and other services. The Company is not engaged in any business operations and has not generated any revenue.
Employees
-
Sector
-
Date Price Change Volume
26-08-03 US$0.9626 -9.19% 290,500
26-07-31 US$1.060 0.00% 1,834,840
26-07-30 US$1.060 +6.96% 130,173
26-07-29 US$0.9910 -4.71% 129,992
26-07-28 US$1.040 -14.75% 585,070
  1. Stock Market
  2. Stocks
  3. NVAC Stock